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Abstract 
 
Background 
Within the last century, Type 2 diabetes mellitus has become one of the major health 
concerns both in the US and globally.  Overall prevalence and incidence of the disease 
within younger populations including adolescents and young adults has sharply increased 
since 1990 and is estimated to increase further if no actions are taken.   It is estimated that 
5.7 million people have a form of diabetes. Of the total estimated prevalence of T2DM, 
25% of persons with diabetes are unaware they have the disease.  This study aims to 
identify populations most at risk as well as to label important risk factors associated with 
the rise of T2DM within the young adult population.      
Objectives 
This study aimed to measure the prevalence of diagnosed and undiagnosed T2DM among 
different populations based on ethnicity, socioeconomic status, and weight classification 
among a representative sample of young adults within the United States.  This study also 
aims to identify and quantify associated risk factors of T2DM among young adults, and 
address current preventative and treatment measures.   
Methods 
Six two-year samples of the National Health and Nutrition Examination Survey 
(NHANES) containing a total of 62,160 individuals were compiled into one dataset.  Of 
these, 11,874 young adults aged 20-40 were selected into the study. 
Prevalence of diagnosed and undiagnosed T2DM was calculated for specific populations. 
The study also aimed to identify important risk factors through univariate and 
multivariate binomial logistic regression analysis.    
Results 
Among young adults aged 20-40, overall prevalence of T2DM was found to be 1.4% (CI: 
1.2-1.6%).  Of observed diabetes cases, an alarming 20.1% (N = 68) were categorized as 
undiagnosed.  Significant increases in risk were observed within older age groups, 
overweight and obese weight categories, individuals living below poverty and within 
minority racial/ethnic groups. 
Weight, measured by both BMI (OR: 10.7; CI:5.88-19.44) and waist circumference (OR: 
5.29; CI: 3.18-8.79), was identified as the most influential risk factor, and should be a 
main area of focus in development of interventions. 
Increases in activity levels, both at work and during leisure-time, were found to decrease 
one’s risk of having T2DM.     
Discussion 
Type 2 diabetes has become a major health concern within the past decades, and will 
continue to be an area of focus in the future.  If current trends of diabetes among the 
young continue, significant burden will be placed on both health facilities as well as on 
the economy. 
Based on the findings from this study, further research should be place on prevention 
methods aimed at altering life-style behaviors such as diet and exercise early in one’s life.  
Based on the alarming prevalence of undiagnosed cases, continued research and support 
should also be place on access to care for minorities, especially persons of Latin 
American decent. 
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1. Introduction 
 
1.1 Type Two Diabetes Mellitus: History, Classification and Definition 
 
 Diabetes is quickly becoming one of the most important issues facing public 
health today, however it is not a new disease.  The earliest description of the disease dates 
back to 1550 BC where it was described as a condition of passing too much urine 
(Ahmed 2002).  Documented within the 5th and 6th centuries, Indian doctors observed a 
sweet honey-like taste to patient’s urine.  They also noticed that the disease occurred in 
two different populations: the older more obese and within the young who did not survive 
past childhood. (Narayan 2011) 
 There were early reports within the 17th century, documenting an increasing 
incidence of diabetes.  Thomas Willis (1621 – 1675) noticed, “Although the disease was 
rare in ancient times its frequency is increasing.”  With increases in incidence and 
prevalence, public health and medicine were forced to develop strategies to defend 
against the increasing burden of disease.  Standardizations of classifications of the 
different forms of hyperglycemia were necessary for epidemiological studies, diagnosis, 
and other areas of research.   
 Urine testing was the standard diagnosis tool used for diabetes and other forms of 
hyperglycemia until the mid 20th century.  Oral glucose tolerance tests (OGTTs) later 
replaced urine tests and became the gold standard. (ADA 1969)  These tests were useful 
in identifying patients with abnormal glucose tolerance.  However, healthy post-load 
categorical values changed with age, which made uniform standardizations difficult 
(Andres 1967).  In 1965, the World Health Organization (WHO) made the first attempt to 
provide recommendations for international standardization. (WHO Expert Committee 
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1965) Unfortunately, these recommendations were not widely accepted.  During this time, 
there were three classifications for diabetes based on the distinguishing pattern of age: 
adult-onset, juvenile-onset and secondary diabetes, which was a broad category which 
included: chronic pancreatitis, hemochromatosis and endocrinopathies.   
 In 1979 and 1980 the National Diabetes Data Group (NDDG) and WHO both 
release updated recommendations that emphasized a need for uniform standardization.   
Additional research had become available that helped differentiate between the two main 
types of diabetes: those who presented associations with specific HLA types and who had 
islet cell antibodies, and another group who showed no associations with HLA types or 
had islet cell antibodies present.  Researchers also noticed that the first group was at high 
risk of ketoacidosis if not treated with insulin (Rushford et al. 1979).  Because of these 
new findings, new names were given: Insulin-dependent and non-insulin dependent 
diabetes.  Focus switched from age of an individual at disease onset to whether insulin 
was needed to maintain homeostasis. 
   The 1979 and 1980 recommendations also included new measurement 
assessments of glucose concentrations.  Both reports recommended using venous plasma 
rather than whole blood tests.  Both studies claimed that variation in red-cell volume led 
to different glucose levels.  The NDDG recommendations included diagnostic criteria 
based on the plasma glucose exam.  Those satisfying one or both of the following tests 
were labeled as diabetic. 
 
! ≥140mg/dL fasting glucose level 
! ≥200mg/dL 2hr post 75g oral glucose load 
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 These recommendations were generally accepted internationally for around 
twenty years until 1997, when the American Diabetes Association (ADA) (Gavin et al. 
1997) and the WHO (1998-1999)  (WHO Consultation Group 1999) published new 
reports, which amended the labels of the two main types of diabetes, as well as updated 
new diagnostic criteria.  The old names were relabeled to type 1 and type 2 based on new 
findings of the pathophysiologic process of type 1 diabetes.  The pathophysiologic 
process of type 2 diabetes, however, remained unclear.  These reports lowered the 
threshold for diagnosis from a fasting glucose level of 140mg/dL to 126mg/dL, and 
included a new category labeled “impaired fasting glycemia”, who’s fasting glucose 
threshold ranged from 110mg/dL to 125mg/dL.  This group was later labeled as “pre-
diabetes” in 2003, and the threshold was lowered to 100mg/dL so that more preventative 
measures could be taken to help slow the progression of diabetes (Genuth et al. 2003). 
 Our current standards come from the most recent WHO report published in 2006 
(WHO/IDF Consultation Group 2006).  Very little was amended from the 1997-1999 
recommendations except the changing of the “pre-diabetic” group’s label to 
“intermediate hyperglycemia” based on negative social stigmas.   The 75g OGTT is still 
the current gold standard for diagnostic testing. However, there is increasing controversy 
regarding its use. 
 
• Diabetic: ≥126mg/dL fasting glucose level 
• Intermediate Hyperglycemia: 110-125mg/dL fasting glucose levels 
 
 
    Arguments for diagnosis based on A1C use led to its consideration within the 
2006 report, however lack of availability of HbA1C tests in developing regions led to its 
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omission (Narayan 2011).  Current research in improving diagnostic tools such as 
HbA1C tests may lead to future recommendations.      
 
   
1.2 Complications associated with T2DM 
 
 Diabetes increases one’s risk of many serious and debilitating life-long 
complications including: acute metabolic complications, vision loss, chronic kidney 
disease, lower-extremity diseases and cardiovascular disease (CVD).  Risk of  severe 
complications increases with time spent with the diseases as well as if diabetes is left 
untreated, or if compliance of corrective behavior is low.  Likewise, if T2DM is detected 
early and if proper lifestyle behavioral changes are made, adverse complications can be 
delayed or even prevented. (ADA 2014) 
 For the purpose of this thesis, I will not review these associated complications in 
detail.  However, they are included to underscore the potential value of early recognition 
and early treatment.  
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1.3 Purpose of Study  
 
1.3a General Objective 
 
 The purpose of this study is to identify recent trends in prevalence and 
distribution of diagnosed and undiagnosed type 2 diabetes mellitus (T2DM) cases among 
American young adults.   The study aims to identify populations most at risk and to 
identify populations who would benefit most from strategic intervention strategies.  
Additionally, this study seeks to identify major risk factors associated with T2DM, and to 
identify significant trends that may correspond with the increasing prevalence of T2DM.  
 
1.3b Specific Objectives 
 
1. Calculate the prevalence of diagnosed and undiagnosed T2DM in young adults 
ageing 20-40 using continuous NHANES data compiled from six datasets (1999-
2010). 
2. Analyze the distribution of T2DM among age groups, weight categories, different 
racial/ethnic groups and among individuals living above or below poverty. 
3. Calculate odds ratios of risk factors associated with T2DM using univariate and 
multivariate binary logistic models to assess the importance of each factor. 
4. Analyze trends of associated risk factors to attempt to illustrate correlations that 
may be present.  
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2. Review of Literature: 
 
 
2.1 Burden of disease 
 
 Type 2 diabetes mellitus (T2DM) has quickly become one of the most common 
non-communicable diseases in both developed and developing countries. (Chen et al 
2011)  Since 1990, there has been a sharp increase in both prevalence and incidence 
among all age groups.  T2DM is one of the leading causes of death in developed 
countries, and is considered an epidemic in most developing countries.  Until recently, 
T2DM had only been diagnosed in adults.  This has changed completely and is now also 
a major health concern for adolescences and young adults.  This increase in prevalence 
and incidence among the young is especially important to monitor since it greatly affects 
the most productive years of one’s life and also places a more substantial long-term strain 
on the health care system.  Complications from T2DM including: coronary artery and 
peripheral vascular disease, stroke, diabetic neuropathy, and amputations. Renal failure 
and blindness contribute to a substantial physical and economic burden, especially when 
symptoms appear in the younger populations or are left untreated. (D’Adamo, Caprio 
2011;Pinhas-Hamiel 2007) The CDC estimates that 25% of people with diabetes are 
unaware that they have the disease. (CDC 2008)  Factors suspected for surplus amount of 
undiagnosed cases include: lack of access to care, lack of awareness, inaction of the 
provider in addition to T2DM being asymptomatic in its early stages.  In developing 
countries the estimated prevalence of undiagnosed diabetes reaches 70% within rural 
regions. (Mohan et al. 2005) 
Worldwide prevalence of T2DM has increased due to several factors including: 
population growth, urbanization, aging and an increasing prevalence of overweight and 
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obesity.  According to one study, the number of people living with diabetes globally is 
expected to double from 2000 to 2030, from 171 million cases to over 300 million in 
2030 based solely on demographic changes. (Wild et al. 2004) In the development of 
their predictions Wild and her colleagues assumed that obesity rates and age-specific 
prevalence of T2DM would remain constant.  Because of this, their estimates are 
expected to be conservative and likely an underestimate of the true projected figure. 
(Wild et al. 2004)  Similar results were found in a Canadian study. (Ohinmaa et al. 2000) 
In the United States, similar increasing trends in prevalence and incidence can be 
observed.  Since the mid 1950’s, the number of individuals diagnosed with T2DM has 
increased from 1.6 million Americans in 1958 to 23.6 million in 2007.  The number of 
diagnoses is predicted to increase to 48.3 million Americans by 2050.  The total 
prevalence of T2DM of all ages has increased from 0.9% in 1958 to 5.9% in 2005, and is 
expected to continue to increase to 12.0% in 2050. (Narayan 2011) 
 The physical and economic burden of T2DM and associated complications are not 
evenly distributed among populations.  All individuals do not share an equal risk of 
acquiring the disease.  It has been established that different ethnicities, age groups, 
gender, weight class and socioeconomic strata are all factors that contribute to one’s risk. 
(DPH)  
 
 
2.2 Burden among adolescents and young adults: 
 
 Diabetes Mellitus is one of the most common chronic diseases in children and 
adolescents. (National Diabetes Data Group 1995)  Most of these cases are type 1 
diabetes mellitus (T1DM), however incidence and prevalence of type 2 diabetes mellitus 
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(T2DM) within the adolescent population is on the rise. (SEARCH for Diabetes in the 
Youth Study Group 2006)  There is substantial evidence that correlates the rise in T2DM 
incidence among adolescents with the recent epidemic of increased childhood overweight 
and obesity.  Similar trends as seen in adult population affected by T2DM, there have 
been a disproportionate increase among minority populations including: African 
American, Hispanic, Asian and Native American youths. (SEARCH for Diabetes in 
Youth Study Group 2006) (Alberti et al. 2004; Fagot-Campagna et al. 2000)      
  
 
 
2.3 Risk factors 
 
 The causes of Type 2 diabetes mellitus are complex and interwoven.  It is 
important to approach identifying risk factors at an ecological level; identifying risk 
factors within social policies, communities, personal behaviors, pathophysiological 
pathways and most specifically one’s genetic construct.  
 Because diabetes is greatly influenced by behavioral factors that if changed could 
prevent or lessen the severity of the disease, focus has been placed on modifiable “life-
style” factors as well as certain non-modifiable risk factors such as SES, race/ethnicity 
and gender.  Further research of these risk factors is important because modification 
one’s behaviors and/or environment within early years may have a significant impact on 
one’s risk of developing the disease.    
      
2.3a Modifiable risk factors 
 
 The major factors influencing the increase in incidence of T2DM have been 
strongly associated with several significant modifiable “life style” risk factors such as 
	   14	  
weight management, dietary intake, physical inactivity and smoking.   Weight gain and 
obesity drastically increase the risk, and physical inactivity further compounds the risk., 
while smoking has been associated with a lesser increase in risk. (Hu et al 2007) T2DM 
and associated complications can be prevented, slowed or even reversed if caught early 
enough by altering these modifiable “life-style” factors.         
 
 
 
 
 
2.3b Overweight/Obesity 
 
 Over the past 50 years, incidence of overweight and obesity has increased. (Parikh 
et al. 2007)  For the period 2003-2004 the overall prevalence of overweight or obesity 
among men was 70.8% and in women 61.8%. (Ogden et al. 2006)  These staggering 
figures suggest that the majority of people are at an increased risk of developing T2DM.  
Overweight can be defined as having a body mass index (BMI) (calculated by kg/m2) of 
25-29.  Similarly, obesity is categorized as a BMI of 30 or higher. Current	  research	  suggests	  that	  excess	  body	  fat	  is	  the	  single	  most	  important	  determinant	  of	  type	  2	  diabetes.	  	  (Hu	  et	  al.	  2007)	  
 However, based on a study that used national survey data, the age and race 
adjusted prevalence of obesity over a 12-year period between 1999-2010, showed no 
significant increase among women overall (OR: 1.01; 95%CI: 1.00-1.03).   This indicates 
that the obesity epidemic may be slowing down.  However, within the same study, 
increases in prevalence of obesity were statistically significant for non-Hispanic black 
women and Mexican American women. For men, there was a significant linear trend 
(OR: 1.04; 95% CI: 1.02-1.06) over the 12-year period. (Flegal et al. 2012).    
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 Recently, there has been a copious amount of research demonstrating the link 
between overweight and obesity with an increased risk T2DM. In one prospective cohort 
study, researchers found that when compared with the normal weight group (BMI: 18.5-
24.9), age-adjusted odds ratios for overweight and obese men developing T2DM were 
2.73 (95%CI: 2.05-3.64) and 7.26 (95%CI: 5.26-10.04), respectively. (Hart et al. 2007) 
 In a study of women, the relative risk of T2DM was found to be 38.8 for severely 
obese women (BMI: ≥35) and 20.1 for obese women (BMI: 30-34.9), when compared 
with women who had a normal body-mass index of less than 23.0. (Hu et al. 2001) 
Abdominal obesity has also been identified as a significant risk factor.  Freemantle and 
his team found a strong association between waist circumference and incidence of T2DM 
(OR: 2.14 95% CI: 1.70–2.71; p < 0.001). (Freemantel et al. 2008)  Other studies suggest 
using waist circumference as a good indicator of future risk for T2DM in daily primary 
care. (Siren et al. 2012; Okosun et al. 1998)   
 Similarly to increasing trends in BMI, waist circumference and abdominal obesity 
among both American men and women have also been on the rise. (li et al. 2007) 
With over half of the American population above the normal threshold for BMI, weight 
will remain to be a pivotal factor in the fight against T2DM and an area of future research.  
 
 
 
 
2.3c Dietary Intake 
 
 Consumption of “healthy” foods such as whole grains, fiber and unsaturated fats 
is important in the prevention and reversal of T2DM.  Consumptions of “unhealthy” 
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foods such as foods high in sugar and saturated fats may increase one’s risk of acquiring 
the disease. (Franz et. al 2002)   
 Reducing intake of fats, particularly saturated fats, may decrease one’s risk for 
diabetes independent of weight status. (Franz et. al 2002)  Excess dietary fat consumption 
may also have secondary health effects that are important in the development of T2DM.  
In obese individuals, consumption of dietary fats may have a negative effect on insulin 
sensitivity. (Mayer-Davis et al. 1997).  Saturated fats such as butter and lard may have 
the largest impact on insulin activity.  Alternatively, both monounsaturated and 
polyunsaturated fat intake, in appropriate doses, may reduce the risk of t2dm. (Meyer et 
al. 2001) 
 Consumption of whole grains and fiber have been associated with a reduction in 
risk for t2dm. (Franz et al. 2002; Meyer et al. 2000; Schulze et al. 2004a)  Consumption 
of foods containing whole grains and fiber have also been associated with higher insulin 
sensitivity. (Liese et al. 2003) 
 
2.3d Physical Activity 
 Physical activity is an important protective factor associated with prevention or 
delay of T2DM and associated complications. (Jeon et al. 2007)  In a systematic review 
of more than 300,000 participants, there was a protective effect (RR:0.69; 95%CI:0.58-
0.83) for participants who regularly participated in moderate physical activity when 
compared with no regular activity.   The study also found a protective effect (RR: 0.7; 
95%CI:0.58-0.84)  of regular walking (>2.5hrs per week) on T2DM incidence when 
compared to no physical activity. (Jeon et al. 2007)  
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 In addition, increased moderate to vigorous activities have also been associated 
with higher insulin sensitivity. (Mayer-Davis et al. 1998) In a meta-analysis conducted in 
2006, researchers found a significant protective effect (RR 0.83) of moderate-intensity 
activities with development of T2DM. 
 Other studies suggest that physical activity is a proxy for weight loss. (Hamman et 
al. 2006).  However, with substantial strong evidence demonstrating moderate activity 
reducing one’s risk by ~30%, it is hard to contribute to weight loss alone.  Physical 
activity is a key modifiable behavioral factor and should remain a major area of focus in 
consideration of future prevention programs.   
 
 
2.3e Smoking 
 
 Smoking has been well studied and is associated with an increased risk for many 
chronic diseases including T2DM (Narayan 2011) As part of the IRAS prospective study, 
associated increased risk was observed between current smokers and development of 
T2DM (OR: 2.66) when compared to non-smokers.  The risk more than doubled if one 
had more than a 20 pack-year history prior to the study (OR: 5.66). (Foy et al. 2005; Hu 
et al. 2001)  
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2.4 Non-Modifiable Risk Factors 
 
2.4a Socioeconomic Status 
 
 The mechanism by which socioeconomic status (SES) affects the development of 
T2DM is relatively unclear.  Individuals of low SES, whether measured by education or 
income, have an increased risk of diabetes. (Geiss et al. 2006; Robbins et al. 2005)  
Possible explanations of how SES affects one’s risk include less access to care, higher 
stress levels, negative environmental exposures and low levels of health literacy. 
(Berkman et al. 2004) 
 
2.4b Race/Ethnicity 
 
 There is ample research that describes the unequal distribution of risk among 
different racial/ethnic groups. (Geiss et al. 2006; McBean et al. 2004; CDC 2008)  
Generally, racial minorities have the highest risk of T2DM, and also have higher 
prevalence rates. (Burrows et al. 2000; CDC 2008; Kenny et al. 1995)  Not only do 
minority groups have a higher prevalence, but they also tend to develop the disease at an 
earlier age.  This exacerbates the amount of burden placed on these populations.  
American Indian populations tend to have the highest prevalence, however there is much 
variability among tribes. (Burrows et al. 2000)  Non-Hispanic blacks and Hispanics also 
have increased prevalence in the United States when compared with non-Hispanic whites. 
(CDC 2007)  
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2.5 Preventative and Treatment Measures: 
 
 Type 2 diabetes mellitus is a complex condition that results from an unknown 
combination of genetic and environmental factors.  In spite of the fact that there is limited 
knowledge regarding susceptibility mechanisms for prevention, T2DM has been 
proposed as a preventable disease.  The main reasons for such a proposal are because 
major risk factors, such as obesity and inactivity are potentially modifiable, people at 
high risk are easily identifiable and there is usually a long period of abnormal glucose 
regulation that can be seen prior to disease onset that may be controllable with drugs or 
behavioral changes. (Knowler et al. 1995)   
 Within the last twenty years there has been progress in the form of treatment 
research.  New evidence from recent randomized control trials (RCT), suggest that 
T2DM could be delayed or even prevented in high-risk persons by several different 
routes including: drug treatment focused on diet, exercise, and weight loss. (Inzucchi et al. 
2012)  The Finish Diabetes Prevention Study tested lifestyle change interventions that 
included: weight reduction, dietary fat intake regulation, saturated fat intake regulation, 
fiber intake regulation and moderate exercise of more than 30 minutes per day.  This 
experimental group was then compared to a control group who received little to no health 
advice.  Results from this study demonstrated a 58% reduction in incidence over a three-
year period. (Tuomilehto et al. 2001) 
 Treatment of T2DM with medications that impose strict glycemic control have 
recently become a controversial issue.  The point of contention is that long-term strict 
glycemic control could have an adverse effect on cardiovascular disease outcomes among 
diabetic patients. (Nathan et al. 2005; Holman 2008)  
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Recent studies such as the PROactive randomized control trial, present encouraging 
results that find no association between long term glycemic control and CVD events, 
however the controversy is far from over.  (Dormandy  et al. 2005)      
 Further research is still required especially in the field of pharmacologic 
approaches versus behavioral interventions as well as in comparing different 
pharmacologic agents with each other. 
 
 
 
 
3. Materials & Methods 
 
 All analysis was preformed using SPSS version 21.  Data used for this study were 
obtained through the National Health and Nutrition Examination Survey (NHANES) 
conducted by the National Center for Health Statistics (NCHS), part of the Centers for 
Disease Control and Prevention (CDC).  The NHANES is a multi-staged probability 
sample that selects participants who are representative of the civilian, non-
institutionalized United States.  This study used twelve years of data from 1999-2010.  
The data consists of six data sets of two-year cycles (eg. 1999-2000, 2001-2002, 2003-
2004, 2005-2006, 2007-2008, 2009-2010).  (NHANES 2014) Each two-year dataset 
consisted of ~10,000 individuals and collected data via questionnaire, physical 
examination and laboratory analysis.  Participation rates ranged from 78% to 84% for the 
six datasets. 
 The original population of individuals included in the six data sets (N=62,160) 
was reduced to include only participants who answered the NHANES diabetes 
questionnaire (N= 19, 269).  Of this sub-sample, further restrictions where enforced to 
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include only young adults whose reported age at the time of the interview was 20 – 40 
years old (N=11,874). 
 The NHANES protocol was approved by the National Center for Health Statistics 
institutional review board, and written consent was obtained from all participants.  The 
Georgia State University institutional review board has also accepted the NHANES data, 
and no IRB application was required prior to use of this secondary data. 
 
3.1 Diabetes Classification 
 
 Diagnosis of diabetes was defined on the self-report of a previous diagnosis of 
diabetes by a physician or other health professional, as done in previous studies of this 
kind (Fagot-Campagna et al. 2001; Duncan 2006; Demmer 2013) Participants who self-
reported use of no medication or use of any blood glucose-lowering medications (with or 
without the use of insulin) were categorized as having T2DM.  Participants who reported 
previous diabetes diagnosis and receiving insulin therapy were categorized as having 
T1DM.  This method isn’t perfect, however it is less likely to underestimate the 
prevalence of T2DM and has little impact on the underestimation of T1DM.  
Individuals included into the fasting sub-sample (N=5,126) were used to categorize 
undiagnosed diabetes cases.  Undiagnosed cases were defined as having a fasting blood 
glucose concentration of 126mg/dL or higher, and who answered “No” to the 
questionnaire question regarding having a previous diagnosis by a physician or other 
health professional.  All undiagnosed diabetes cases found were categorized as 
undiagnosed T2DM. 
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 Prevalence estimates of diabetes were obtained from using only the interview 
sample, due to the small sample size of those who participated in having their fasting 
plasma glucose measured. 
   
 
3.2 Fasting Glucose Assessments (sub-sample) 
 
 Of those who participated in the fasting blood glucose measurement, fasting status 
was verified via interview prior to blood collection.  During the first three datasets, 
(1999-2004), glucose measurements were performed by the Diabetes Diagnostic 
Laboratory at the University of Missouri-Columbia using the Cobas Mira Chemistry 
System (Roche Diagnostic Systems Inc., Montclair, New Jersey).  For the 05-06 dataset, 
measurements were completed by the Fairview Medical Center Laboratory at the 
University of Minnesota using a Roche/Hitachi 911 Analyzer (Roche Diagnostics, 
Indianapolis, Indiana). For the remaining two datasets (07-10), glucose measurements 
were performed at the University of Minnesota, using the Roche Modular P Chemistry 
Analyzer (Roche Diagnostics).  In all of the datasets, fasting plasma glucose was 
measured using the hexokinase enzymatic method. (NANES  2014)    
     
 
3.3 Physical Activity: 
 
 Three variables were created to measure the effect of both physical activity and 
duration of inactivity: Leisure-time sedentary behavior (LTSB), Moderate to Vigorous 
Physical activity (MVPA) and usual occupational/ domestic activity (UODA).  Self-
reported data from the physical activity questionnaire were used to create each variable.  
Unfortunately,  the survey questions were not the same throughout the twelve year study 
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period.  Because of this, LTSB and MVPA are measured using only available data from 
specific years.  
 Similarly to previous studies, LTSB was created using two questions: 1) “Over 
the past 30 days, on average how many hours per day did you sit and watch TV or videos 
outside of work?” and, 2) “Over the past 30 days, on average about how many hours per 
day did you use a computer or play computer games outside of work?” Response options 
for both questions included: 1) “none,” 2) “less than 1 hour,” 3) “1 hour,” 4) “2 hours,” 5) 
“3 hours,” 6) “4 hours,” and 7) “5 hours or more.” 
 Self-reported responses were compiled into two categories (≥3 or <3 hrs/day). 
(Sisson et al. 2009)  These questions were only available within the 2003-2004 and 2005-
2006 datasets. 
 The MVPA variable was created from self-reported data only available within the 
2007-2008 and 2009-2010 datasets, that aimed to categorize an individual’s amount of 
physical activity throughout a normal day and includes measurement of duration of active 
transportation (walking or biking), household/domestic tasks and leisure-time physical 
activity.  Four questions were taken from the physical activity questionnaire: 1) “Over the 
past 30 days, have you walked or bicycled as part of getting to and from work, or school, 
or to do errands?” and, 2) “Over the past 30 days, did you do any tasks in or around your 
home or yard for at least 10 minutes that required moderate or greater physical effort?” 
Participants who answered “Yes” to either question were asked to report the frequency 
and duration of these activities. Moderate and vigorous leisure-time physical activity 
were evaluated with two additional questions: 1) “Over the past 30 days, did you do 
moderate activities for at least 10 minutes that cause only light sweating or a slight to 
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moderate increase in breathing or heart rate?” and 2) “Over the past 30 days, did you do 
any vigorous activities for at least 10 minutes that caused heavy sweating, or large 
increases in breathing or heart rate?” Participants who answered “Yes” to either question 
were asked to specify the activities they engaged in and the usual duration and frequency 
of these activities.”  Times reported for each variable were complied and translated into 
min/week.  Based on previous studies as well as from recommendations from the U.S. 
Department of Health and Human Services 2008 physical activity guidelines, two 
categories were created (≥150 or <150 min/week). (Schuna et al. 2013; U.S. Department 
of Health and Human Services: 2008)  
 Lastly, the UODA variable was created to measure one’s daily work/domestic 
activity.  To create this variable a single question from the physical activity questionnaire 
was used: “Please tell me which of these four sentences best describes your usual daily 
activities?”.  Two categories were then created which separated those who responded to 
this question as mostly sitting to compare with those who mostly stand or walk, climb 
stairs or hills often or heavy work as previously done in another study. (Sisson et al. 
2009) 
 
 
3.4 Socioeconomic Status: 
 
 Socioeconomic status was measured using poverty to income ratio (PIR) as has 
been done in previous studies. (Sabanayagam & Shankar 2012)  To compare between 
groups PIR was categorized into quartiles.  PIR quartiles were calculated individually for 
each two-year interval and categorized into: the lowest 25%, 25-50%, 50-75% and the 
top 25% before being compiled with other two-year intervals.  Comparisons were also 
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made between people in poverty (PIR ≤1) and young adults above the poverty threshold 
(>1). 
 
 
 
3.5 Obesity and Waist Circumference: 
 
 Both BMI (calculated kg/m2 ) and waist circumference were used to 
measure overweight and obesity.  According to the World Health Organization, 
BMI should be categorized as: 
 
BMI Weight Status 
Below 18.5 Underweight 
18.5 – 24.9 Normal 
25.0 – 29.9 Overweight 
30.0 and Above Obese 
 
The WHO’s guidelines for waist circumference are sex specific.  Men who have a 
waist circumference of 40 inches or more and women who have a waist 
circumference of 35 inches or more are at and increased risk for many chronic 
diseases including T2DM. (WHO 2003)   
 
3.6 Smoking 
 
 Smoking was assessed solely on the respondents answer to the question within the 
smoking questionnaire, which asks if the respondent is currently smoking.  Other studies 
discriminated between current smokers and former smokers and found no significant 
associations however, this same study did find associations relating to histories of 20 or 
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more pack-years, however since we are examining a young population it is unbeneficial 
to examine this at this time. (Foy et al. 2005)  
 
 
 
3.7 Diet 
 
 Diet was only assessed for the last three intervals (2005-2006, 2007-2008 & 
2009-2010).  Prior to 2005, NHANES did not have a question regarding one’s daily 
dietary habits.  In 2005, NHANES introduced the question: “In general, how healthy is 
your overall diet?” With five possible answers: excellent, very good, good, fair or poor, 
as well as two for don’t know or refuse.   
   
  
3.8 Statistical Analysis 
 
 All analysis was preformed using SPSS version 21.  Descriptive analysis 
was preformed to assess the make up of the study sample. 
Prevalence of T2DM was calculated by taking cases of T2DM found and dividing 
them by the total study population.  95% confidence intervals were also calculated 
to assure statistical significance.  Stratifications were preformed by gender, race, 
SES and BMI to analyze the distribution of T2DM among these groups.    
To calculate odds ratios of associated risk factors, univariate and multivariate 
binomial multivariate logistic models were constructed for the compiled dataset.  
Variables were tested against the outcome of having T2DM or not.  Categorical 
variables were examined and defined using one of the categories as a reference 
group.  Within the multivariate analysis BMI was the selected variable used to 
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adjust for weight for all variables except for waist circumference.  Adjusted OR 
for waist circumference was adjusted for age, gender, race, SES, smoking and 
UODA.  Adjustment for LTSB, MVPA and diet were only conducted and adjusted 
for from only the years that data was available. 
 
 
 
4. Results 
 
4.1 Study Sample: 
 
 Of the 11,874 individuals included in this study 54.4% were female. The study 
population had an average age of 29.84 (SE: 0.056) years.  The ethnic/racial composition 
of the study sample included 43.1% non-Hispanic white, 31.4% Latin American, 20.3% 
non-Hispanic black and 5.2% other/multi-racial.  The study sample had a mean body 
mass index (BMI) of 28.2, and a mean waist circumference of 94.4.  The sample’s mean 
plasma glucose was 95.6 mg/dL. 
 There were significant differences in mean age between the combined subsets.  
The 2005-2006 cohort had an average age of 29.46 which was significantly younger than 
both the 2007-2008 and 2009-2010 cohorts (30.05, 30.42; p=<.001).  There were also a 
significant difference between gender, PIR, BMI and Waist Circumference distributions 
among the six subgroups (p=<.001), which made have made it difficult to measure trends 
within the datasets.        
 
4.2 Prevalence and Distribution 
 
 There were a total of 339 cases of diabetes mellitus found within the study 
population.  The total prevalence of Diabetes within the study sample of young adults 
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aged from 20-40 years was 2.9% (CI: 2.6-3.2%) Of the total cases, 48% (N=163; PR: 
1.4%; CI: 1.2-1.6%) were found to be T2DM, 31.9% (N=108; PR: 0.93%; CI: 0.75-1.1%) 
T1DM, and an alarming 20.1% (N=68; PR: 0.57%; CI: 0.45-0.72%) had a fasting plasma 
glucose >126mg/dL, but had not received a diagnosis of diabetes from a health 
professional and labeled as undiagnosed cases. 
The distribution of T2DM among individuals of differing ages, racial/ethnic groups, and 
socioeconomic groups (Table1) was found to be unequal.     
 Among the four age categories, prevalence increased significantly with increasing 
age.  The 20-24 age group had a prevalence of 0.2% (CI: 0.1-0.4%), the 25-29 age group 
had a prevalence of 0.8% (CI: 0.6-1.2%), 30-34 age group had a prevalence of 1.4% (CI: 
1.1-2.0%) and the 35-40 aged group had the highest prevalence of 2.8% (CI: 2.0-3.0%).  
Between the oldest two quartiles, prevalence of undiagnosed diabetes was found to be 
significantly higher than the lower two quartiles. The oldest age quartile including 
individuals aged 35-40 contained 64.7% of all undiagnosed cases.    
 Among racial/ethnic groups, minorities had a significantly higher prevalence of 
T2DM when compared to non-Hispanic whites (0.9% CI: 0.6-1.2%).  There was no 
significant difference among the prevalence rates between minority groups; Latin 
Americans (1.5% CI: 1.2-1.9%), non-Hispanic blacks (2.0% CI: 1.5%-2.7%) and 
Other/multi-racial (2.3% CI: 1.4%-3.8%). Latin Americans had a significantly higher 
prevalence of undiagnosed T2DM (Prevalence:0.88%; CI: 0.62-1.2%) than non-Hispanic 
whites (Prevalence: 0.41%; CI: 0.27-0.63). 
 Individuals within the top 25% of economic status as measured by income to 
poverty ratios (PIR) had a significantly lower prevalence (0.8% CI: 0.5-1.2%) of T2DM 
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than the lower three quartiles; 50-75% (1.4% CI: 1-1.8%), 25-50% (1.5% CI: 1.1-2.1) 
and the lowest 25% (1.8% CI: 1.3-2.4%).   Prevalence of undiagnosed diabetes was 
approximately equal for each group, even when the group was made dichotomous and 
categorized as being above or below poverty.  
 Overweight and obese populations had significantly higher prevalence of T2DM 
and undiagnosed diabetes than normal and underweight people.  Obese individuals had a 
prevalence of 3.1% (CI: 2.6-3.7%) T2DM and 1.5% (CI: 1.1-1.9%) of  undiagnosed 
diabetes.  Overweight individuals had a prevalence of 0.86 (CI: 0.6-1.2) of T2DM and 
0.71% (CI: 0.48-1.0%) of undiagnosed T2DM. 
 
4.3 Trends 
 
 There were no significant trends of T2DM prevalence found over the time period 
from 1999-2010.  T2DM prevalence ranged from its lowest in 1999-2000 1.3% (CI: 
0.8%-2.0%) to the highest in 2007-2008 1.7% (CI: 1.3-2.4%).   Trends in 
overweight/obesity measures were also found to be insignificant, except for a significant 
difference in waist circumference between 1999-2000 (44% CI: 42-47%) and 2005-2006 
38% (CI: 36-40%). 
 To assess trends among different racial and ethnic groups, proportional changes 
were observed throughout the six two-year time increments.  No clear increasing or 
decreasing changes occurred.  There were differences among proportion of T2Dm among 
racial groups, however because of the small number of cases within each group, no 
significant differences were found.  Non-Hispanic whites consistently had a lower 
proportion compared to the other racial groups with exception of within the 2007-2008 
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period when the proportion of NHW (1.63%) with T2DM was higher than both Latin 
Americans (LA) (1.16%) and multi-racial (1.03%). 
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Table 1: Prevalence of Self-Reported Type 2 and Undiagnosed Diabetes Mellitusa Among 11,874 US 
Young Adults Aged 20-40 Years, NHANES, 1999-2010 
 
Abbreviations: CI, confidence interval.  NHANES, National Health and Nutrition Examination Survey. 
a Included study participants were asked “Have you been told by a doctor or health professional that you 
have diabetes or sugar diabetes?”  Young adults who responded, “Yes” and reported use of oral diabetic 
pills to lower blood sugar or no use of any medication were categorized as having T2DM.  Individuals 
reporting never been told of diabetes and had a plasma glucose of >126mg/dL were categorized as 
Undiagnosed cases.   
b Number of non-institutionalized US young adults aged 20-40 years.  
c Including Mexican Americans and Other Hispanic. 
d Including Asian/Pacific Islander, American Indian and multiracial. 
e Measured using income to poverty ratio.  Individuals who have calculated ratios equal to one or more 
were placed within the above poverty group.  Young adults below the threshold were classified as below 
poverty.  
f Body mass index is calculated: kg/m2.  
g Underweight is combined with normal group, so that any protective effect from being unhealthy is not 
mistaken to be a safe preventative measure.  
 
 
  
Total 
number of 
peopleb   All Diabetes     
Undiagnosed 
Diabetes   
    N % 95%CI N % 95%CI 
Total 11874 163 1.4 1.2-1.6 68 0.57 0.45-0.72 
Age         
 20-24 2988 6 0.2 0.09-0.44 6 0.2 0.09-0.44 
 25-29 2813 23 0.82 0.55-1.2 12 0.43 0.25-0.75 
 30-34 2769 40 1.44 1.06-1.96 6 0.22 0.1-0.48 
 35-40 3304 94 2.85 2.3-3.47 44 1.33 0.99-1.78 
Gender         
 Male 5419 68 1.3 0.9-1.6 43 0.79 0.59-1.1 
 Female 6455 95 1.5 1.2-1.8 25 0.39 0.26-0.57 
Race/Ethnicity         
 Non-Hispanic White 5118 44 0.9 0.6-1.2 21 0.41 0.27-0.63 
 Latin Americanc 3734 56 1.5 1.2-1.9 33 0.88 0.62-1.2 
 Non-Hispanic Black 2409 49 2 1.5-2.7 11 0.46 0.26-0.82 
 Other/Multiraciald 613 14 2.3 1.4-3.8 3 0.49 0.17-1.4 
Socioeconomic Statuse         
 Above Poverty 8320 100 1.2 0.9-1.4 44 0.53 0.4-0.71 
 Below Poverty 2640 47 1.78 1.3-2.4 14 0.53 0.32-0.89 
 Missing Income data 914 16 1.75 1.1-2.8 10 1.1 0.59-2.0 
Body Mass Indexf         
 Underweight/Normalg 4015 12 0.3 0.17-0.52 10 0.25 0.14-0.46 
 Overweight 3497 30 0.86 0.6-1.2 25 0.71 0.48-1.0 
 Obese 3541 110 3.1 2.6-3.7 52 1.5 1.1-1.9 
 Missing BMI data 821 11 1.3 0.75-2.38 4 0.49 0.19-1.3 
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4.4 Risk factors: 
 
 Using both Univariate and multivariate binomial logistic regression models, odds 
ratios were calculated to attribute a quantifiable increase or decrease of one’s risk to risk 
factors found to be associated with T2DM, as well as to assess which risk-factors should 
receive the most attention.   
 Age, BMI, waist circumference, race/ethnicity, socioeconomic status (SES), 
leisure time sedentary behavior (LTSB) and moderate to vigorous physical activity 
(MVPA) were all found to be significantly associated with T2DM.  Gender, smoking, 
usual occupational daily activity (UODA), and Diet were all found to be not significant.   
Table 2 shows the outcomes of both the univariate and multivariate models as well as 
there associated odds ratios. 
 
 
Table 2:  Univariate and Multivariate Binomial Logistic Regression Models of Associated Risk 
Factors With T2DM Among Eligible Subjectsa, NHANES 1999-2010. 
   1999-20101     1999-20102,h   
Variable OR 95%CI p OR 95%CI p 
Age        
20-24 Ref - - Ref - - 
25-29 4.097 1.66-10.08 0.002* 2.84 1.11-7.23 .029* 
30-34 7.285 3.08-17.21 <.001* 4.89 2.02-11.82 <.001* 
35-40 14.55 6.37-33.27 <.001* 10.32 4.42-23.65 <.001* 
Gender        
Males Ref - - Ref - - 
Females 1.18 .859-1.61 0.312 1.06 0.74-1.53 0.74 
Body Mass Index        
Normal/Underweight Ref   Ref - - 
Overweight 2.89 1.48-5.65 .002* 2.18** 1.07-4.44 .032* 
Obese 10.7 5.88-19.44 <.001* 8.14** 4.33-15.29 <.001* 
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Race/Ethnicity        
Non-Hispanic White Ref   Ref   
Latin Americanb 1.76 1.18-2.61 .005* 1.5 0.96-2.34 0.073 
Non-Hispanic Black 2.39 1.59-3.61 <.001* 1.7 1.07-2.70 .026* 
Other/Multiracialc 2.7 1.47-4.95 .001* 2.48 1.18-5.22 .017* 
Waist Circumference        
Normal Ref - - Ref - - 
At Risk 5.29 3.187-8.792 <.001* 4.38 2.54-7.55 <.001* 
Socioeconomic Statusd        
Below Poverty Ref - - Ref - - 
Above Poverty 0.67 0.47-0.95 .025* 0.66 0.45-0.98 .037* 
Smoking        
Active Ref - - Ref - - 
Abstain 0.87 0.52-1.46 0.876 0.82 0.47-1.43 0.491 
UODA        
Mostly Sitting Ref - - Ref - - 
Stand/Walk/Lift 0.763 0.56-1.05 0.763 0.84 0.536-1.32 0.841 
Diete             
Excellent Ref - - Ref - - 
Very Good 0.97 0.31-3.06 0.957 0.76 0.23-2.53 0.659 
Good 1.44 0.51-4.06 0.492 1.23 0.43-3.54 0.697 
Fair 1.46 0.51-4.2 0.485 0.95 0.323-2.82 0.932 
Poor 1.1 0.29-4.11 0.893 0.69 0.18-2.65 0.59 
LTSBf             
>3hrs Ref - - Ref - - 
<3hrs 1.86 1.09-3.19 .024* 2.17 1.19-3.96 .011* 
MVPAg             
<150 min/week Ref - - Ref - - 
>150 min/week 0.47 0.27-0.82 .008* 0.52 0.29-0.93 .028* 
Abbreviations: UODA, usual occupational/domestic activity. LTSB, Leisure-time sedentary behavior. MVPA Moderate to Vigorous 
physical activity.  
1 Univariate binomial logistic regression model. 
2 Multivariable binomial logistic regression model. 
a Number of non-institutionalized US young adults aged 20-40 years.  
b Including Mexican Americans and Other Hispanic. 
c Including Asian/Pacific Islander, American Indian and multiracial. 
d  Measured using income to poverty ratio.  Individuals who have calculated ratios equal to one or more were placed within the above 
poverty group.  Young adults below the threshold were classified as below poverty.  
e The question “In general, how healthy is your diet?” used to determine individuals diet, was only available for intervals 2005-2006, 
2007-2008 and 2009-2010.  The multivariate model was only conducted for data from those six years to calculate associated Odds 
Ratio.  Adjustment for waist circumference was not preformed.   
f The data available for this variable was only available within the 2003-2004 and 2005-2006 intervals.  The multivariate model was 
only conducted for this variable from data from the four-year period.  Adjustment for waist circumference was not preformed. 
g The data available for this variable was only available within the 2007-2008 and 2009-2010 interviews.  The multivariate analysis 
was conducted using only data from this time period.  Adjustment for waist circumference was not preformed. 
h When conducting the multivariate analysis,  BMI and waist circumference were not adjusted in tandem. 
* Indicates statistical significance 
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4.4a Age 
 
  Age was found to be a major risk factor for T2DM.  Reported ages were grouped 
into quartiles, (20-24, 25-29, 30-34 and 35-40).   The number of participants was evenly 
distributed among groups (~25%).  Univariate analysis of age using the youngest age 
group as the reference group discovered that the age groups of 25-29, 30-34, and 35-40 
had increased odds ratios of 4.10 (CI: 1.66-10.08; p=.002), 7.29 (CI: 3.08-17.21; 
p=<.001) and 14.55 (CI: 6.37-33.27; p=<.001) respectively of having T2DM. 
 When adjusted for gender, BMI, race/ethnicity, SES, smoking, and UODA age 
remained a significant risk factor.  Using the youngest age group as the reference group, 
individuals in other quartiles remained to all have significant OR’s: 25-29 OR: 2.84 (CI: 
1.11-7.23; p=.029), 30-34 OR: 4.89 (CI: 2.02-11.82; p=<.001), and 35-40 OR: 10.32 (CI: 
4.42-23.65; p=<.001). 
 
4.4b Weight Management: 
 
 Overweight, obesity and increased abdominal obesity were also found to be a 
major contributor of one’s risk of having T2DM.  Univariate analysis demonstrated that 
when compared with individuals categorized with having an underweight/normal BMI, 
individuals categorized as being overweight had 2.89 (CI: 1.48-5.65; p=.002) the risk of 
having T2DM.  Individuals categorized as obese also had an increased risk of T2DM. 
(OR: 10.7 CI: 5.88-19.44; p=<.001) 
 Individuals who had a waist circumference that categorized them as at risk had an 
increased risk of 5.29 (CI: 3.19-8.79; p=<.001) of having T2DM when compared with 
individuals with a waist circumference within the normal range.      
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Significance remained when adjusting for other associated risk factors in a Multivariate 
regression analysis.  When adjusting for age, gender, race/ethnicity, SES, smoking and 
UODA individuals who were classified as overweight had a OR of 2.18 (CI: 1.07-4.44; 
p=.032) when compared to individuals within the normal/underweight category.   
Individuals categorized as obese had an OR of 8.14 (CI: 4.33-15.29; p=<.001).   
 Waist circumference also remained significant when adjusted for age, gender, 
race/ethnicity, SES, smoking, and UODA.  Individuals who had a waist circumference 
that placed them at risk had an OR of 4.38 (CI: 2.54-7.55; p=<.001) when compared to 
those who had a waist circumference within the normal range.   
 
4.4c Race/ethnicity: 
 
 Both univariate and multivariate analysis of self-reported race/ethnicity found 
significant differences of risk associated with different minority racial/ethnic groups 
when compared to non-Hispanic whites..  When compared within non-Hispanic whites, 
persons of Latin American origins had an OR of 1.76 (CI: 1.18-2.61; p=.005).  Non-
Hispanic backs and other/multi-racial groups also had increased OR’s of 2.39 (CI: 1.59-
3.61; p=<.001) and 2.7 (CI: 1.47-4.95; p=.001) respectively.   
 When adjusted for age, gender, BMI, SES, smoking and UODA, the significance 
between non-Hispanic whites and individuals of Hispanic origins was lost.  Non-Hispanic 
blacks and individuals of other/multi-racial origins had OR’s of 1.7 (CI: 1.07-2.70; 
p=.026) and 2.48 (CI: 1.18-5.22; p=.017) respectively when compared to non-Hispanic 
whites.    
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4.4d Socioeconomic status: 
 
 Individuals were compared based on their reported income, which was used to 
calculate their poverty to income ratio (PIR).  For univariate analysis, individuals were 
compared based on their poverty status.  Individuals above poverty had an OR of 0.67 
(CI: 0.47-0.95; p=.025) when compared to those below poverty. 
 
 
   
 
4.4e Physical activity/inactivity 
 
 Three variables were created to measure one’s average physical activity: moderate 
to vigorous physical activity (MVPA), usual occupational or domestic activity (UODA) 
and leisure-time sedentary behavior.   Univariate models showed a significant associated 
between T2DM and LTSB and MVPA.  UODA was found to be insignificant (p = .763). 
LTSB was divided into two categories: those who on average spent three hours or more 
either watching TV or on the computer per day, and those who reported less than three 
hours per day.  Individuals who reported spending on average more than three hours per 
day had an OR of 1.86 (CI: 1.09-3.19) when compared to those who spent less than three 
hours sedentary.  LTSB remained significant and actually contributed more to one’s risk 
when adjusted for age, gender, BMI, race/ethnicity, SES, smoking, and UODA; OR: 2.17 
(CI: 1.19-3.96 p=.011). 
 MVPA was divided into two groups as well, those who on average, spent 150 
min/week or less participating in moderate to vigorous acuities during their leisure time, 
and those who reported more than 150min/week activity.   Individuals who reported more 
than 150min/week had an OR of 0.47 (CI: 0.27-0.82 p=.008).  When adjusted for age, 
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gender, BMI, race/ethnicity, SES, smoking and UODA, MVPA remained a significant 
protective risk factor for those who reported on average participating 150mins/week or 
more of moderate and/or vigorous activity OR: 0.52; CI: 0.29-0.93 p=.028). 
 
 
 
 
 
 
5. Discussion 
    
 
 Findings from this study support previous evidence that proclaim T2DM as a 
major emerging health concern for young adults and adolescents, and with 
overweight/obesity prevalence climbing to 70% within the US, we have yet to reach the 
zenith.  It is clear that the disease affects a disproportionate number of minority persons 
and is highest among overweight and obese populations.  Prevalence of undiagnosed 
diabetes was also found to be disproportionately distributed among racial/ethnic groups.   
T2DM among young adults share similar risk factors as older populations with disease.  
This is important in that similar prevention and treatment strategies could possibly be 
used among the young adult population.     
 This study addressed major risk factors associated with T2DM including SES, 
ethnicity, physical activity, diet and obesity.  High OR figures suggest that weight plays a 
prominent role in a young adult’s risk of having or acquiring the disease.  Risk trends 
within weight and race/ethnicity variables were explored over the twelve-year time 
period, however, there were no significant changes found.  I speculate that with a greater 
amount of data predating 1999, that there would be trends correlations with increased risk 
among overweight and obesity, due to the evolution of the role of processed foods within 
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our culture as well as a decrease in risk among racial/ethnic groups due to a decreasing 
gap between those who have and those who don’t. 
 Analysis of risk factors associated with T2DM found that the same factors driving 
the risk of the disease among young adults were the same for the disease among the adult 
population. (Hu et al. 2001)  Though this is promising, speculation and research should 
investigate whether implementation of adult oriented interventions would be efficacious 
among young adults.   
 Future research should focus on creating processes that catch potential or early 
cases before the disease fully develops.  Screening may be an important potential solution.  
Screening of high-risk population with the use of economical finger prick blood glucose 
tests may be an effective and efficient solution that is currently being studied. (Anand et 
al. 2006)   
 Limitations of this study include potential variability of results due to a small 
sample size of cases of diagnosed and undiagnosed T2DM among sub-samples (eg. 
Ethnicity).  Over estimation from oversampling could potentially inflate outcome values 
among minority populations.  In addition, the analytical software used lacked the ability 
of weighting, and therefore results cannot be extrapolated to generalize the US population. 
 T2DM has a potentially promising outlook if necessary steps are taken.  T2DM 
has been defined by some as a curable disease if caught and treated early enough with a 
combination of drug therapy, dietary adjustments as well as physical activity.   
Investment in screening as well as new diagnostic tools such as ethnicity-specific 
diabetes risk scores would greatly reduce the number of undiagnosed cases.  Control 
interventions should focus on decreasing overweight and obesity prevalence since weight 
	   39	  
seems to be the driving force behind.  Some recent studies suggest that obesity rates have 
already slowed and may even have plateaued. (Flegal et al. 2012)  However, with the 
majority of the US population categorized as overweight or obese, there is still a lot of 
work left to be completed. 
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